Pediatrix Medical Group, Inc. $MD Stock Sold by Royce & Associates LP

Royce & Associates LP reduced its stake in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 8.9% during the third quarter, HoldingsChannel reports. The firm owned 833,031 shares of the company’s stock after selling 81,317 shares during the quarter. Royce & Associates LP’s holdings in Pediatrix Medical Group were worth $21,434,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank of America Corp DE acquired a new position in Pediatrix Medical Group during the 2nd quarter worth approximately $7,837,000. The Manufacturers Life Insurance Company bought a new position in Pediatrix Medical Group in the 2nd quarter valued at approximately $1,030,000. SummerHaven Investment Management LLC lifted its stake in Pediatrix Medical Group by 92.7% in the 3rd quarter. SummerHaven Investment Management LLC now owns 111,299 shares of the company’s stock valued at $2,864,000 after purchasing an additional 53,534 shares during the last quarter. Tidal Investments LLC boosted its position in Pediatrix Medical Group by 253.9% in the second quarter. Tidal Investments LLC now owns 616,048 shares of the company’s stock valued at $15,604,000 after buying an additional 441,959 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new stake in Pediatrix Medical Group in the second quarter valued at approximately $1,854,000. 97.71% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 13th. Truist Financial upped their price target on shares of Pediatrix Medical Group from $28.00 to $31.00 and gave the stock a “hold” rating in a report on Friday, October 30th. Weiss Ratings upgraded Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, September 9th. Jefferies Financial Group downgraded Pediatrix Medical Group from a “buy” rating to a “hold” rating and raised their price objective for the company from $27.00 to $28.00 in a report on Wednesday, August 19th. Finally, Mizuho downgraded Pediatrix Medical Group from a “neutral” rating to an “underperform” rating and set a $28.00 price objective on the stock. in a report on Wednesday, November 11th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Pediatrix Medical Group has a consensus rating of “Hold” and a consensus target price of $28.00.

Get Our Latest Research Report on Pediatrix Medical Group

Pediatrix Medical Group Stock Up 0.2%

Shares of MD opened at $31.35 on Monday. The company has a market capitalization of $2.45 billion, a PE ratio of 17.04 and a beta of 0.62. Pediatrix Medical Group, Inc. has a 12 month low of $17.23 and a 12 month high of $33.74. The stock’s 50-day moving average price is $27.88 and its two-hundred day moving average price is $24.34. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 0.47.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.07. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. The firm had revenue of $501.37 million for the quarter, compared to analyst estimates of $498.18 million. During the same quarter in the previous year, the company posted $0.67 EPS. The business’s revenue was up 1.7% on a year-over-year basis. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 2.22 EPS for the current year.

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.

Recommended Stories

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.